Type 2 Diabetes mellitus (T2DM) is a foremost health concern worldwide, as well as in India, contributing about 17% of the global burden of T2DM.1 It is observed that despite the advancement and availability of several therapeutic options, majority of diabetic population fails to achieve the optimal glycemic goal of glycated hemoglobin (HbA1c) <7%.2 This article enlightens about the treatment patten for drug naïve T2Dm patients.